Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus dexmedetomidine for reducing bleeding during functional endoscopic sinus surgery
IRCT20160430027677N20Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of clonidine and dexmedetomidine in epistaxis (3 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Amount of bleeding. Started May 2019; status: completed.
02
Drugs
clonidinedexmedetomidine
03
Conditions
epistaxis
Beyond the preview
Go deeper on IRCT20160430027677N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160430027677N20.